Skip to main content
. 2024 May 8;51(11):3252–3266. doi: 10.1007/s00259-024-06741-7

Table 1.

Subject characteristics

Healthy controls PSP patients Disease controls
Part I of the study
  Total number 8 10 2
  Subgroups NA PSP-RS (n = 7), PSP-non-RS (n = 3) PD (n = 1), FTD (n = 1)
  Age, mean 70 years 71 years 66 years
  Sex female (n = 4), male (n = 4) female (n = 5), male (n = 5) male (n = 2)
  Disease duration, mean NA 39 months NA
Part II of the study
  Total number 15 15 10
  Subgroups NA PSP-RS, (n = 12), PSP-non-RS (n = 3) AD-DEM (n = 8), AD-MCI (n = 2)
  Age, mean 69 years 69 years 67 years
  Sex male (n = 8), female (n = 7) male (n = 7), female (n = 8) male (n = 2), female (n = 8)
  Disease duration, mean NA 54 months 32 months